Rovi rises on full-year earnings beat
25/02/2026 09:45
** Shares in Rovi ROVI.MC rise about 3% after the Spanish drugmaker's full-year earnings beat analyst expectations ** Rovi's 2025 net profit came in at 140.4 million euros ($165.50 million), around 10% higher than the 127.5 million euros estimated by analysts polled by LSEG ** "We raise our PT to 90.0 euros per share (+28% vs. previous; +15% vs potential) after revising our EBITDA estimates for 2026-2028e upwards by +5%," Banco Sabadell says ** The stock is up about 27% since the start of the year and at its highest level since September 2024 ($1 = 0.8483 euros) (Reporting by Javi West Larrañaga) ((javier.west@thomsonreuters.com; +34 918 35 61 12))